Article

Experts Publish Call to Action to Prevent Hospital-Acquired Pneumonia

Although it is the most common hospital-acquired infection, hospitals are not required to report non-ventilator-associated hospital-acquired pneumonia to the CDC National Healthcare Safety Network.

A task force of health care leaders recently published a national call to action, urging increased focus on the prevention of non-ventilator-associated, hospital-acquired pneumonia (NVHAP).

Most hospitals do not have systems in place to track or report NVHAP, according to a press release. Furthermore, most health systems do not have active prevention initiatives, even though NVHAP is the most common hospital-acquired infection.

NVHAP has significant negative patient outcomes, including 15% to 30% mortality rates, extended hospital lengths of stay, unexpected intensive care unit admissions of up to 46%, and an increased risk for hospital readmission within 30 days, according to the press release.

Unlike cases of pneumonia associated with ventilators and other device-associated hospital-acquired infections, NVHAP is not recognized as an indicator in the National Database of Nursing Quality, and the Centers for Medicare and Medicaid Services do not require hospitals to report cases to the CDC National Healthcare Safety Network. NVHAP is also not included in pay-for-reporting or performance programs.

“Adding NVHAP to these lists of high-stakes conditions is one way to draw hospitals’ attention to NVHAP, to catalyze the discovery of optimized prevention initiatives and implementation strategies, and drive down NVHAP incidence and morbidity,” the white paper said, according to the press release.

NVHAP is a major research focus for Karen K. Giuliano, PhD, RN, FAAN, MBA, a member of the task force and an associate professor at the University of Massachusetts Amherst. Giuliano worked with other task force members to develop recommendations to improve research and prevention efforts to reduce harm from NVHAP, according to the press release.

In addition to raising awareness, the white paper recommends educating patients, health care professionals, and students about prevention measures. These strategies can include standardized, therapeutic oral care for all patients, implementing surveillance strategies, and supporting research to develop new strategies for both surveillance and prevention.

“The hidden harm from NVHAP in acute care is a significant patient safety issue,” Giuliano said in the press release. “NVHAP should be elevated to the same level of concern, attention, and effort as prevention of [ventilator-associated pneumonia] in hospitals.”

The call to action was developed by a joint task force of health care stakeholders, including the CDC, the Veterans Health Administration, the Joint Commission on Accreditation of Healthcare Organizations, the American Dental Association, the Patient Safety Movement Foundation, Oral Health Nursing Education and Practice and the Teaching Oral-Systemic Health program. It was published in Infection Control & Hospital Epidemiology.

REFERENCE

Health Care Leaders Call for National Focus on Preventing Hospital-Acquired Pneumonia. News release. University of Massachusetts Amherst. June 22, 2021. Accessed June 23, 2021. https://www.umass.edu/news/article/health-care-leaders-call-national-focus-preventing-hospital-acquired-pneumonia

Related Videos
Senior Doctor is examining An Asian patient.
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Hurricane Helene, Baxter plant, IV fluids shortage, health systems impact, injectable medicines, compounding solutions, patient care errors, clinical resources, operational consideration, fluid conservation, sterile water, temperature excursions, training considerations, patient safety, feedback request
Image Credit: © peopleimages.com - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC